The UK NEQAS for Acute and Chronic Kidney Disease Scheme includes CKD, AKI and we are currently piloting KFRE on a quarterly basis (KFRE is not yet accredited to ISO/IEC 17043). You can participate in either, or both, the AKI and CKD elements of the Scheme.

Due to the nature of the AKI element of the Scheme which looks at historical data, there will be, by necessity, restricted time points where you can join. New participants to this Scheme will be able to join:

  • Up to 1st May 2024 and will receive specimens from Distribution 209
  • Up to 1st August 2024 and will receive specimens from Distribution 212
  • Up to 1st Sept 2024 and will receive specimens from Distribution 213
  • Up to 1st Jan 2025 and will receive specimens from Distribution 216
  • Up to 1st April 2025 and will receive specimens from Distribution 219
  • Up to 1st May 2025 and will receive specimens from Distribution 220

If you are interested in participating in KFRE please contact Birmingham Quality.

Scheme Particulars Indicative Details
Accreditation body UKAS
UKAS Accredited Proficiency Testing Provider No 7860
Number of distributions per year (nominal) 11
Specimens per distribution 3 (Separate specimens for Creatinine for eGFR, Creatinine for AKI and Cystatin C)
Frequency of distribution Monthly
Material distributed Pooled, liquid human serum with or without exogenous added analyte
Nominal sample volume (mL) 0.5 (0.25 mL Cystatin C)
Programme Director(s) / Organiser(s) Finlay MacKenzie
Analyte Approximate Range Default Scheme Units
AKI stage AKI stage 1,2,3 and all other flags
Cystatin C 0 – 10 mg/L
eGFR 2009 CKD-EPI SCr 10 – >90 mL/min/1.73m2
eGFR CKD-EPI Cys 10 – >90 mL/min/1.73m2
eGFR MDRD 10 – >90 mL/min/1.73m2
expected eGFR 2009 CKD-EPI SCr 10 – >90 mL/min/1.73m2
expected eGFR CKD-EPI Cys 10 – >90 mL/min/1.73m2
expected eGFR MDRD 10 – >90 mL/min/1.73m2
Serum creatinine - AKI 25 – 500 µmol/L
Serum creatinine - CKD 25 – 500 µmol/L
  • Download Acute and Chronic Kidney Disease 2024 schedule 53 KB

Last Updated: